Related Experiment Videos
Micro-albuminuria and large vessel disease in diabetes
1Steno Memorial Hospital, Gentofte, Denmark.
Insights
Diabetic nephropathy is linked to cardiovascular disease risk factors like high blood pressure and abnormal lipid levels. Albuminuria may indicate widespread vascular issues in patients with diabetes mellitus.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Endocrinology
Background:
- Atherosclerosis significantly contributes to morbidity and mortality in insulin-dependent diabetes mellitus.
- Albuminuria is a recognized predictor of cardiovascular disease in diabetic patients, with early stages correlating to high coronary heart disease incidence.
- Diabetic nephropathy patients exhibit established cardiovascular risk factors, including hypertension, dyslipidemia, elevated fibrinogen, and potential platelet hyper-reactivity.
Purpose of the Study:
- To explore the association between diabetic nephropathy and generalized vascular disease.
- To investigate the role of albuminuria as a marker for vascular complications in diabetes mellitus.
Main Methods:
- Analysis of cardiovascular risk factors in patients with diabetic nephropathy.
- Assessment of transcapillary albumin escape rate.
- Measurement of plasma von Willebrand's factor levels.
- Evaluation of fibrinolytic capacity in early diabetic nephropathy.
Main Results:
- Patients with diabetic nephropathy present with multiple cardiovascular risk factors.
- Albuminuria may serve as an indicator of systemic vascular wall disease.
- Elevated transcapillary albumin escape, increased von Willebrand's factor, and impaired fibrinolysis are observed in early diabetic nephropathy.
Conclusions:
- The underlying pathophysiological mechanisms of diabetic nephropathy remain largely hypothetical and require further investigation.
- Albuminuria's role as a marker for generalized vascular disease in diabetes warrants continued research.
Background:
Atherosclerosis is a major cause of morbidity and mortality in insulin-dependent diabetes mellitus. Recent studies have shown that albuminuria is a predictor of cardiovascular disease in these patients and there is a particularly high incidence of coronary heart disease in the early stages of albuminuria.
Available Evidence:
A number of established cardiovascular risk factors, such as elevated blood pressure, atherogenic changes in the plasma concentrations of lipids and lipoproteins, elevated plasma levels of fibrinogen and, probably, hyper-reactivity of platelets are present in patients with diabetic nephropathy. Further, albuminuria may be a marker of generalized disease in the vascular wall of small and large blood vessels. Findings of an elevated rate of transcapillary albumin escape, an elevated plasma concentration of von Willebrand's factor and impaired fibrinolytic capacity in early diabetic nephropathy support this hypothesis.
Conclusion:
The initial pathophysiological mechanisms involved in diabetic nephropathy are still hypothetical and largely unknown.